ConductScience.org, home

Paper39239559

Integrins in cancer stem cells.

Gou S and 2 others. Front Cell Dev Biol, 2024. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Integrins in cancer stem cells. Papers, record 39239559. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39239559

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integrins in cancer stem cells.
PubMed
Journal
Front Cell Dev Biol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
1.41, provisional
iCite
Revised in PubMed
2026-09-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gou SSiqi
2Wu AAnqi
3Luo ZZhigang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References168

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119588168Integrin-mediated adhesion and stem-cell-niche interactions.Cell Tissue Res2010https://conductscience.org/library/papers/19588168PubMed
230817927Integrin signaling and mechanotransduction in regulation of somatic stem cells.Exp Cell Res2019https://conductscience.org/library/papers/30817927PubMed
331263095IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway.Cell Death Dis2019https://conductscience.org/library/papers/31263095PubMed
421838596Integrin α3β1 as a breast cancer target.Expert Opin Ther Targets2011https://conductscience.org/library/papers/21838596PubMed
523604127Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis.Oncogene2014https://conductscience.org/library/papers/23604127PubMed
630892939Integrin-α7 signaling regulates connexin 43, M-cadherin, and myoblast fusion.Am J Physiol Cell Physiol2019https://conductscience.org/library/papers/30892939PubMed
721996747CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.Oncogene2012https://conductscience.org/library/papers/21996747PubMed
837834343Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions.Int J Mol Sci2023https://conductscience.org/library/papers/37834343PubMed
929198914Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.Cancer Cell2017https://conductscience.org/library/papers/29198914PubMed
1012471617Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion.Int J Cancer2003https://conductscience.org/library/papers/12471617PubMed
1130889378Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.Cancer Cell2019https://conductscience.org/library/papers/30889378PubMed
1223708747CD49f-positive cell population efficiently enriches colon cancer-initiating cells.Int J Oncol2013https://conductscience.org/library/papers/23708747PubMed
1334205341Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells.Cancers (Basel)2021https://conductscience.org/library/papers/34205341PubMed
1430627776Blockade of integrin β3 signals to reverse the stem-like phenotype and drug resistance in melanoma.Cancer Chemother Pharmacol2019https://conductscience.org/library/papers/30627776PubMed
1536219689Targeting integrin α2 as potential strategy for radiochemosensitization of glioblastoma.Neuro Oncol2023https://conductscience.org/library/papers/36219689PubMed
1635561877LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis.Cancer Lett2022https://conductscience.org/library/papers/35561877PubMed
1732323968Cell-Cell Adhesion-Driven Contact Guidance and Its Effect on Human Mesenchymal Stem Cell Differentiation.ACS Appl Mater Interfaces2020https://conductscience.org/library/papers/32323968PubMed
1834805482Advancing cell instructive biomaterials through increased understanding of cell receptor spacing and material surface functionalization.Regen Eng Transl Med2021https://conductscience.org/library/papers/34805482PubMed
1931789398Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma.Int J Oncol2020https://conductscience.org/library/papers/31789398PubMed
2027765911Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.Oncotarget2016https://conductscience.org/library/papers/27765911PubMed

See all 168 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41942631Stress-responsive membrane proteins as execution nodes of tumor cell adaptation to microenvironmental stress.Oncogene2026https://conductscience.org/library/papers/41942631PubMed
41888835Integrins in cancer: insights into mechanisms and therapeutic potential.Cell Commun Signal2026https://conductscience.org/library/papers/41888835PubMed
41683993Mesenchymal Stem Cell-Derived Exosomes Reprogram Chemosensitivity Pathways in Cervical Cancer Spheroids.Int J Mol Sci2026https://conductscience.org/library/papers/41683993PubMed
41601637Dual function antibody targeting αvβ3 and PD-L1 provide a promising strategy for solid tumor therapy.Front Immunol2025https://conductscience.org/library/papers/41601637PubMed
41309738Transfer learning with multiomics integration and deep neural networks reveals drug resistance mechanisms in cancer.Sci Rep2025https://conductscience.org/library/papers/41309738PubMed
40771808Targeting CSC-immune cell crosstalk to overcome chemoresistance and enhance immunotherapy efficacy.Front Immunol2025https://conductscience.org/library/papers/40771808PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39239559

GET https://conductscience.org/api/papers/v1/39239559/references?page=2